He also has untreated sleep apnea. He would like to try one of the GLP-1 drugs to lose some weight, but I am concerned about ...

Furoscix is expected to be available for CKD patients in April 2025. The Food and Drug Administration (FDA) has expanded the approval of Furoscix ® (furosemide injection) to include the treatment ...

Future Cardiol. 2012;8(5):707-728. These data come from reports of ototoxicity of 6.4% with furosemide compared with 1 and <1% for bumetanide and torsemide, respectively. [38] Acute kidney failure ...

He is 5 feet, 7 inches tall, and weighs 270 pounds. He is treating his fluid retention with 100 mg of furosemide daily. He also has mild, untreated sleep apnea. He would like to try one of the GLP ...

He is 5 feet, 7 inches tall, and weighs 270 pounds. He is treating his fluid retention with 100 mg of furosemide daily. He also has mild, untreated sleep apnea. He would like to try one of the GLP-1 ...